Advances in the field of pharmacogenetics have brought much attention to the potential benefit of personalized medicine in the field of psychiatry. We will assess the value of a simple pharmacogenetic test for treatment-seeking CAF veterans. If the results from prior depression studies hold in our PTSD population, this approach holds potential to save time and money and accelerate the path to recovery by matching treatment to the profile of each patient, and therefore improving treatment outcomes (Hall-Flavin et al., 2013).